Whitebox Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-88,343
Closed -$1.53M 353
2023
Q3
$1.53M Sell
88,343
-47,000
-35% -$980K 0.05% 112
2023
Q2
$2.82M Buy
135,343
+84,119
+164% +$1.83M 0.08% 107
2023
Q1
$1.2M Hold
51,224
0.04% 159
2022
Q4
$1.43M Hold
51,224
0.04% 222
2022
Q3
$1.2M Hold
51,224
0.03% 285
2022
Q2
$1.73M Sell
51,224
-10,000
-16% -$350K 0.05% 199
2022
Q1
$2.14M Sell
61,224
-45,937
-43% -$1.57M 0.04% 175
2021
Q4
$3.26M Buy
107,161
+38,797
+57% +$1.26M 0.07% 111
2021
Q3
$2.24M Sell
68,364
-7,000
-9% -$224K 0.05% 146
2021
Q2
$2.28M Buy
+75,364
New +$2.48M 0.05% 133

Other funds holding OGN

Whitebox Advisors's OGN Position: Q4 2023 in Review

Whitebox Advisors sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 88,343 shares — an estimated $1.53M sold.

Whitebox Advisors first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $3.26M in Q4 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Whitebox Advisors reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Whitebox Advisors sold 88,343 Organon & Co shares in Q4 2023, an estimated $1.53M.
  • Whitebox Advisors first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Whitebox Advisors's Organon & Co position peaked at $3.26M in Q4 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Whitebox Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.